Rodgers Brothers’s AstraZeneca AZN Stock Holding History

Rodgers Brothers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Sell	1,330 -100	-7%	-$18.8K	0.02%	227
2026 Q1	$282K	Hold	1,430	–	–	0.03%	215
2025 Q4	$263K	Hold	1,430	–	–	0.03%	215
2025 Q3	$219K	Buy	+1,430	New	+$216K	0.03%	229
2025 Q2	–	Sell	-1,430	Closed	-$210K	–	240
2025 Q1	$210K	Buy	+1,430	New	+$207K	0.03%	226
2024 Q4	–	Sell	-1,430	Closed	-$223K	–	231
2024 Q3	$223K	Hold	1,430	–	–	0.03%	225
2024 Q2	$223K	Buy	+1,430	New	+$215K	0.03%	225
2014 Q2	–	Sell	-3,119	Closed	-$202K	–	149
2014 Q1	$202K	Buy	+3,119	New	+$201K	0.1%	161

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rodgers Brothers's AZN Position: Q2 2026 in Review

Rodgers Brothers reduced its AstraZeneca (AZN) stake by 7% in Q2 2026, selling an estimated $18.8K and leaving 1,330 shares worth $252K. The position accounts for 0.02% of the portfolio, ranked #227.

Rodgers Brothers first reported a position in AZN in Q1 2014 and has held it in 8 quarters since. The position peaked at $282K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Rodgers Brothers held 1,330 shares of AstraZeneca worth $252K as of Q2 2026.
Rodgers Brothers sold 100 AstraZeneca shares in Q2 2026, an estimated $18.8K.
AstraZeneca made up 0.02% of Rodgers Brothers's portfolio in Q2 2026, its #227 holding.
Rodgers Brothers first reported a position in AstraZeneca in Q1 2014 and has held it in 8 quarters since.
Rodgers Brothers's AstraZeneca position peaked at $282K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rodgers Brothers's 13F filing for Q2 2026, filed 5 Aug 2026.